PM14 Administered Intravenously to Patients With Advanced Solid Tumors

Clinical trial NCT05076396 · COMPLETED

Trial details

NCT number: NCT05076396
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2017-09-06
Primary completion: 2025-08-21
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.